CMR Surgical (CMR) has today announced that its Versius® Surgical Robotic System has now been used in 5,000 surgical procedures worldwide.
Versius is now routinely used by surgeons across Europe, the Middle East, Asia, Australia & Latin America. Designed to offer high utilisation in operating rooms, Versius is being used to perform a wide variety of both routine and complex procedures across a range of specialties including gynaecology, colorectal surgery, thoracic surgery, general surgery and urology – from hernia repairs and hysterectomies to radical prostatectomies and lower anterior resections.
The 5,000th procedure was performed at Argenteuil Hospital, a public health centre in Paris, France, where Dr Patrick Bagan and his team performed a successful lung bisegmentectomy for cancer.
Dr Patrick Bagan, Thoracic & Vascular Surgeon and Head of Department, Argenteuil Hospital, commented: “I’m honoured to reach this significant milestone with our partners CMR and the Versius system. I’m delighted to report that this complex procedure went as planned and the patient is recovering well. In thoracic surgery, Versius has transformed how we treat lung cancer at Argenteuil and patients are seeing the benefits.”
“We have two Versius surgical robots here and we routinely complete many successful cases every week. Because it is small and modular, we can easily move the systems around the hospital and we regularly have two Versius procedures in different surgical specialties happening simultaneously,” added Bagan.
Patricia Chesnais, General Manager, France & Benelux, CMR Surgical, commented: “I’m so pleased Argenteuil Hospital is sharing this milestone with us. It has been a great partner since it became the first public hospital in France to start using Versius in 2020. This is a great opportunity to celebrate its successful robotics programme and the impact partnerships like this one are having on patients in France, Europe and the rest of the world.”
While manual minimal access surgery (MAS) can be complex to perform, the benefits for patients are well recognised. Versius has been designed to help patients around the world have access to the benefits of MAS.
Per Vegard Nerseth, Chief Executive Officer, CMR Surgical, commented: “5,000 cases is an important milestone for us at CMR. We set out to transform surgery for patients, and we truly believe we are doing that as we expand into new countries and partner with more and more hospitals and surgeons around the world.”
Source: CMR Surgical.